<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3438</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2021.13504</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Antibacterial Activity of Fused Zinc Oxide Nanoparticles with Bacteriocin Sub Class II B [Lactacin F] Against Shigella Species __ampersandsignndash; A Synergistic Study&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sri</surname><given-names>S. Kaviya</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rose</surname><given-names>Malini Evangeline</given-names></name></contrib><contrib contrib-type="author"><name><surname>Monica</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>Kamala</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>Muthumariyammal</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>Namperipakkam</surname><given-names>Shelina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manipriya</surname><given-names>B.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>3</day><month>03</month><year>2021</year></pub-date><volume>)</volume><issue/><fpage>54</fpage><lpage>57</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Antibacterial effect of zinc oxide nanoparticles (ZnO-NPs) has remarked a huge interest overall especially by the usage of nanotechnology to synthesis particles in the nanometer size. ROS has been a central point for a few systems including cell wall destruction because of ZnO confined communication, improved film porousness, the disguise of NPs because of loss of proton intention power and take-up of poisonous broke up zinc particles. Objective: The antibacterial impact of zinc oxide (ZnO) nanoparticle and bacteriocin on Shigella species. Methods: Preliminary tests have been done for the identification of Lactobacillus acidophilus strains producing bacteriocin. Chloroform__ampersandsignndash;Methanol (2:1 v/v) was used for crude Bacteriocin extraction. However produced precipitate at Solvent-Aqueous interphase was collected aseptically, the solvent was evaporated and the precipitate was kept in a buffer which was used for the antimicrobial study. Sep-pack C18 cartridge and reverse-phase High-Performance Liquid Chromatography on a Nucleosil column were used for purification of lactation F. In this study Agar well diffusion and Broth dilution techniques were used to obtain antimicrobial activity of Lactation F. Synergistic antibacterial activity was done with 1: 1 combination of lactation f and ZnO nanoparticle against. Results: Lactacin F was purified and the antimicrobial testing was done with and without zinc oxide nanoparticle, which shows that Lactation F with zinc oxide nanoparticle had expanded zone of restraint to Shigella species when contrasted with Lactacin F alone. Conclusion: Invitro antibacterial activity of the synergistic compound was more effective than the crude extract of bacteriocin against Shigella species.&#13;
</p></abstract><kwd-group><kwd> Bacteriocin</kwd><kwd> Lactacin F</kwd><kwd> Shigella species</kwd><kwd> Synergy</kwd><kwd> Zinc oxide</kwd></kwd-group></article-meta></front></article>
